JNJ
JOHNSON + JOHNSON DL 1
Stock XETRA – Stock Market Prices, News & Analysis
Johnson & Johnson est une entreprise américaine spécialisée dans les produits pharmaceutiques, les dispositifs médicaux et les produits de soins personnels.
JOHNSON + JOHNSON DL 1
JNJ
Johnson & Johnson est une entreprise américaine spécialisée dans les produits pharmaceutiques, les dispositifs médicaux et les produits de soins personnels.
Price history of JOHNSON + JOHNSON DL 1
Price history of JOHNSON + JOHNSON DL 1
Performance & Momentum
Strategic Analysis
JOHNSON + JOHNSON DL 1 • 2026
Johnson & Johnson relies on an integrated model combining pharmaceuticals, medical devices, and consumer products, providing robust diversification within the healthcare sector. Its ability to innovate in clinical research and its global presence make it a key player, ideally positioned to capture long-term growth in the medical market.
- Balanced sector diversification across pharmaceuticals, medical devices, and personal care
- Global leadership with strong clinical innovation momentum
- Well-known consumer products portfolio generating stable revenues
- Significant exposure to strict healthcare sector regulation
- Vulnerability to pharmaceutical litigation that could affect valuation
Momentum is supported by solid performance across all time frames, indicating a stable and resilient growth profile. This positive dynamic reflects strong investor interest, justifying an optimistic strategic outlook for investors seeking safety and moderate growth.
Similar stocks to JOHNSON + JOHNSON DL 1
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
